MicroRNAs in psychiatric and neurodevelopmental disorders

Brain Research

Volumn 1338, Issue , 2010, Pages 78-88

  Xu, Bin ^a   Karayiorgou, Maria ^a   Gogos, Joseph A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Autism; Chromosome 22q11.2; Mental retardation; MicroRNA; Neurodevelopment; Psychiatric disorder; Schizophrenia; Synaptic plasticity

Indexed keywords

MICRORNA;

AUTISM; BIOGENESIS; COGNITIVE DEFECT; DEVELOPMENTAL DISORDER; DOWN SYNDROME; FRAGILE X SYNDROME; GENE DISRUPTION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC RISK; GILLES DE LA TOURETTE SYNDROME; HUMAN; MENTAL DISEASE; NERVE CELL DIFFERENTIATION; NERVE FUNCTION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; RISK FACTOR; SCHIZOPHRENIA;

ANIMALS; DEVELOPMENTAL DISABILITIES; HUMANS; MENTAL DISORDERS; MICRORNAS; MODELS, NEUROLOGICAL; NERVOUS SYSTEM DISEASES;

EID: 77952583640     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.03.109     Document Type: Review

References (124)

1. Abelson J.F., Kwan K.Y., O'Roak B.J., et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310 (2005) 317-320
2. Abu-Elneel K., Liu T., Gazzaniga F.S., et al. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 9 (2008) 153-161
3. Amir R.E., Van den Veyver I.B., Wan M., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23 (1999) 185-188
4. Archidiacono N., Lerone M., Rocchi M., et al. Rett syndrome: exclusion mapping following the hypothesis of germinal mosaicism for new X-linked mutations. Hum. Genet. 86 (1991) 604-606
5. Armstrong D., Dunn J.K., Antalffy B., et al. Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol. 54 (1995) 195-201
6. Bailey A., Le Couteur A., Gottesman I., et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25 (1995) 63-77
7. Bearden C.E., Woodin M.F., Wang P.P., et al. The neurocognitive phenotype of the 22q11.2 deletion syndrome: selective deficit in visual-spatial memory. J. Clin. Exp. Neuropsychol. 23 (2001) 447-464
8. Beveridge N.J., Gardiner E., Carroll A.P., et al. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry (2009). http://doi:10.1038/mp.2009.84 Advance online publication 1 September 2009. doi:10.1038/mp.2009.84
9. Beveridge N.J., Tooney P.A., Carroll A.P., et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum. Mol. Genet. 17 (2008) 1156-1168
10. Bolduc F.V., Bell K., Cox H., et al. Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nat. Neurosci. 11 (2008) 1143-1145
11. Brunet A., Armengol L., Pelaez T., et al. Failure to detect the 22q11.2 duplication syndrome rearrangement among patients with schizophrenia. Behav. Brain Funct. 4 (2008) 10
12. Bucan M., Abrahams B.S., Wang K., et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 5 (2009) e1000536
13. Cao X., Yeo G., Muotri A.R., et al. Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 29 (2006) 77-103
14. Carothers A.D., Hecht C.A., and Hook E.B. International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age. J. Med. Genet. 36 (1999) 386-393
15. Caudy A.A., Myers M., Hannon G.J., et al. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 16 (2002) 2491-2496
16. Cavanna A.E., Servo S., Monaco F., et al. The behavioral spectrum of Gilles de la Tourette syndrome. J. Neuropsychiatry Clin. Neurosci. 21 (2009) 13-23
17. Cheng L.C., Pastrana E., Tavazoie M., et al. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 12 (2009) 399-408
18. Cho S.C., Yim S.H., Yoo H.K., et al. Copy number variations associated with idiopathic autism identified by whole-genome microarray-based comparative genomic hybridization. Psychiatr. Genet. 19 (2009) 177-185
19. Chou I.C., Wan L., Liu S.C., et al. Association of the Slit and Trk-like 1 gene in Taiwanese patients with Tourette syndrome. Pediatr. Neurol. 37 (2007) 404-406
20. Christian S.L., Brune C.W., Sudi J., et al. Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol. Psychiatry 63 (2008) 1111-1117
21. Conaco C., Otto S., Han J.J., et al. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2422-2427
22. Curtis A.R., Headland S., Lindsay S., et al. X chromosome linkage studies in familial Rett syndrome. Hum. Genet. 90 (1993) 551-555
23. Davis T.H., Cuellar T.L., Koch S.M., et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 28 (2008) 4322-4330
24. Delabar J.M., Theophile D., Rahmani Z., et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur. J. Hum. Genet. 1 (1993) 114-124
25. Deng H., Le W.D., Xie W.J., et al. Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol. Scand. 114 (2006) 400-402
26. Deo M., Yu J.Y., Chung K.H., et al. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev. Dyn. 235 (2006) 2538-2548
27. Devys D., Lutz Y., Rouyer N., et al. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat. Genet. 4 (1993) 335-340
28. Dictenberg J.B., Swanger S.A., Antar L.N., et al. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev. Cell 14 (2008) 926-939
29. Edbauer D., Neilson J.R., Foster K.A., et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65 (2010) 373-384
30. Ellison K.A., Fill C.P., Terwilliger J., et al. Examination of X chromosome markers in Rett syndrome: exclusion mapping with a novel variation on multilocus linkage analysis. Am. J. Hum. Genet. 50 (1992) 278-287
31. Fineberg S.K., Kosik K.S., and Davidson B.L. MicroRNAs potentiate neural development. Neuron 64 (2009) 303-309
32. Fiore R., Khudayberdiev S., Christensen M., et al. Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J. 28 (2009) 697-710
33. Folstein S., and Rutter M. Infantile autism: a genetic study of 21 twin pairs. J. Child Psychol. Psychiatry 18 (1977) 297-321
34. Giraldez A.J., Cinalli R.M., Glasner M.E., et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science 308 (2005) 833-838
35. Glessner J.T., Wang K., Cai G., et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459 (2009) 569-573
36. Greenberg D.A., Hodge S.E., Sowinski J., et al. Excess of twins among affected sibling pairs with autism: implications for the etiology of autism. Am. J. Hum. Genet. 69 (2001) 1062-1067
37. Hagberg B. Rett syndrome: Swedish approach to analysis of prevalence and cause. Brain Dev. 7 (1985) 276-280
38. Hagberg B., Aicardi J., Dias K., et al. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol. 14 (1983) 471-479
39. Han J., Pedersen J.S., Kwon S.C., et al. Posttranscriptional crossregulation between Drosha and DGCR8. Cell 136 (2009) 75-84
40. Hansen T., Olsen L., Lindow M., et al. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2 (2007) e873
41. Hobert O. Gene regulation by transcription factors and microRNAs. Science 319 (2008) 1785-1786
42. Huber K.M., Gallagher S.M., Warren S.T., et al. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 7746-7750
43. Hutvagner G., McLachlan J., Pasquinelli A.E., et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293 (2001) 834-838
44. Ingason A., Rujescu D., Cichon S., et al. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol. Psychiatry (2009)
45. ISC. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 (2008) 237-241
46. Ishizuka A., Siomi M.C., and Siomi H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev. 16 (2002) 2497-2508
47. Jin P., Zarnescu D.C., Ceman S., et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat. Neurosci. 7 (2004) 113-117
48. Kadener S., Rodriguez J., Abruzzi K.C., et al. Genome-wide identification of targets of the drosha-pasha/DGCR8 complex. Rna 15 (2009) 537-545
49. Karayiorgou M., Morris M.A., Morrow B., et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7612-7616
50. Kataoka Y., Takeichi M., and Uemura T. Developmental roles and molecular characterization of a Drosophila homologue of Arabidopsis Argonaute1, the founder of a novel gene superfamily. Genes Cells 6 (2001) 313-325
51. Kates W.R., Krauss B.R., AbdulSabur N., et al. The neural correlates of non-spatial working memory in velocardiofacial syndrome (22q11.2 deletion syndrome). Neuropsychologia 45 (2007) 2863-2873
52. Keen-Kim D., Mathews C.A., Reus V.I., et al. Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum. Mol. Genet. 15 (2006) 3324-3328
53. Kerbeshian J., Peng C.Z., and Burd L. Tourette syndrome and comorbid early-onset schizophrenia. J. Psychosom. Res. 67 (2009) 515-523
54. Kim J., Inoue K., Ishii J., et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317 (2007) 1220-1224
55. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6 (2005) 376-385
56. Kirov G., Gumus D., Chen W., et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet. 17 (2008) 458-465
57. Kirov G., Grozeva D., Norton N., et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 18 (2009) 1497-1503
58. Klein M.E., Lioy D.T., Ma L., et al. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat. Neurosci. 10 (2007) 1513-1514
59. Kocerha J., Faghihi M.A., Lopez-Toledano M.A., et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 3507-3512
60. Kuhn D.E., Nuovo G.J., Martin M.M., et al. Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochem. Biophys. Res. Commun. 370 (2008) 473-477
61. Kuhn D.E., Nuovo G.J., Terry Jr. A.V., et al. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J. Biol. Chem. 285 (2009) 1529-1543
62. Kumar R.A., KaraMohamed S., Sudi J., et al. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 17 (2008) 628-638
63. Lagos-Quintana M., Rauhut R., Yalcin A., et al. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12 (2002) 735-739
64. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
65. Leonard H., and Bower C. Is the girl with Rett syndrome normal at birth?. Dev. Med. Child Neurol. 40 (1998) 115-121
66. Lewandowski K.E., Shashi V., Berry P.M., et al. Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144 (2007) 27-36
67. Lim L.P., Lau N.C., Garrett-Engele P., et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 (2005) 769-773
68. Liu J., Carmell M.A., Rivas F.V., et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305 (2004) 1437-1441
69. Lugli G., Torvik V.I., Larson J., et al. Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. J. Neurochem. 106 (2008) 650-661
70. Makeyev E.V., Zhang J., Carrasco M.A., et al. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell. 27 (2007) 435-448
71. Marshall C.R., Noor A., Vincent J.B., et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82 (2008) 477-488
72. Mellios N., Huang H.S., Baker S.P., et al. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol. Psychiatry 65 (2009) 1006-1014
73. Merenstein S.A., Sobesky W.E., Taylor A.K., et al. Molecular-clinical correlations in males with an expanded FMR1 mutation. Am. J. Med. Genet. 64 (1996) 388-394
74. Miller D.T., Shen Y., Weiss L.A., et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J. Med. Genet. 46 (2009) 242-248
75. Mrak R.E., and Griffin W.S. Trisomy 21 and the brain. J. Neuropathol. Exp. Neurol. 63 (2004) 679-685
76. Muhle R., Trentacoste S.V., and Rapin I. The genetics of autism. Pediatrics 113 (2004) e472-e486
77. Murchison E.P., Partridge J.F., Tam O.H., et al. Characterization of Dicer-deficient murine embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12135-12140
78. Murphy K.C., Jones L.A., and Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 56 (1999) 940-945
79. Napoli I., Mercaldo V., Boyl P.P., et al. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134 (2008) 1042-1054
80. Nomura T., Kimura M., Horii T., et al. MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Hum. Mol. Genet. 17 (2008) 1192-1199
81. O'Rourke J.A., Scharf J.M., Yu D., et al. The genetics of Tourette syndrome: a review. J. Psychosom. Res. 67 (2009) 533-545
82. Obernosterer G., Leuschner P.J., Alenius M., et al. Post-transcriptional regulation of microRNA expression. RNA 12 (2006) 1161-1167
83. Penagarikano O., Mulle J.G., and Warren S.T. The pathophysiology of fragile x syndrome. Annu. Rev. Genomics Hum. Genet. 8 (2007) 109-129
84. Perkins D.O., Jeffries C.D., Jarskog L.F., et al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 8 (2007) R27
85. Pfeiffer B.E., and Huber K.M. Fragile X mental retardation protein induces synapse loss through acute postsynaptic translational regulation. J. Neurosci. 27 (2007) 3120-3130
86. Pillai R.S., Artus C.G., and Filipowicz W. Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis. Rna 10 (2004) 1518-1525
87. Pilpel Y., Kolleker A., Berberich S., et al. Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice. J. Physiol. 587 (2009) 787-804
88. Pulver A.E., Karayiorgou M., Wolyniec P.S., et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. Am. J. Med. Genet. 54 (1994) 36-43
89. Rajasethupathy P., Fiumara F., Sheridan R., et al. Characterization of small RNAs in aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 63 (2009) 803-817
90. Ramachandran V., and Chen X. Degradation of microRNAs by a family of exoribonucleases in Arabidopsis. Science 321 (2008) 1490-1492
91. Robertson M.M. Diagnosing Tourette syndrome: is it a common disorder?. J. Psychosom. Res. 55 (2003) 3-6
92. Schaefer A., O'Carroll D., Tan C.L., et al. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 204 (2007) 1553-1558
93. Scharf J.M., Moorjani P., Fagerness J., et al. Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample. Neurology 70 (2008) 1495-1496
94. Schratt G. microRNAs at the synapse. Nat. Rev. Neurosci. 10 (2009) 842-849
95. Schratt G.M., Tuebing F., Nigh E.A., et al. A brain-specific microRNA regulates dendritic spine development. Nature 439 (2006) 283-289
96. Sebat J., Lakshmi B., Malhotra D., et al. Strong association of de novo copy number mutations with autism. Science 316 (2007) 445-449
97. Sirianni N., Naidu S., Pereira J., et al. Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am. J. Hum. Genet. 63 (1998) 1552-1558
98. Sobin C., Kiley-Brabeck K., Daniels S., et al. Neuropsychological characteristics of children with the 22q11 Deletion Syndrome: a descriptive analysis. Child Neuropsychol. 11 (2005) 39-53
99. Staley D., Wand R., and Shady G. Tourette disorder: a cross-cultural review. Compr. Psychiatry 38 (1997) 6-16
100. Stark K.L., Xu B., Bagchi A., et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40 (2008) 751-760
101. Stefansson H., Rujescu D., Cichon S., et al. Large recurrent microdeletions associated with schizophrenia. Nature 455 (2008) 232-236
102. Steffenburg S., Gillberg C., Hellgren L., et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J. Child Psychol. Psychiatry 30 (1989) 405-416
103. Szatmari P., Paterson A.D., Zwaigenbaum L., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39 (2007) 319-328
104. Talebizadeh Z., Butler M.G., and Theodoro M.F. Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Autism Res. 1 (2008) 307
105. Thomson J.M., Newman M., Parker J.S., et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20 (2006) 2202-2207
106. Triboulet R., Chang H.M., Lapierre R.J., et al. Post-transcriptional control of DGCR8 expression by the Microprocessor. Rna 15 (2009) 1005-1011
107. Tsiouris J.A., and Brown W.T. Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy. CNS Drugs. 18 (2004) 687-703
108. Turner G., Webb T., Wake S., et al. Prevalence of fragile X syndrome. Am. J. Med. Genet. 64 (1996) 196-197
109. Verkerk A.J., Cath D.C., van der Linde H.C., et al. Genetic and clinical analysis of a large Dutch Gilles de la Tourette family. Mol. Psychiatry 11 (2006) 954-964
110. Verkerk A.J., Pieretti M., Sutcliffe J.S., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65 (1991) 905-914
111. Vo N., Klein M.E., Varlamova O., et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 16426-16431
112. Wang Y., Medvid R., Melton C., et al. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 39 (2007) 380-385
113. Wayman G.A., Davare M., Ando H., et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 9093-9098
114. Weiss L.A., Shen Y., Korn J.M., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358 (2008) 667-675
115. Wendland J.R., Kruse M.R., and Murphy D.L. Functional SLITRK1 var321, varCDfs and SLC6A4 G56A variants and susceptibility to obsessive-compulsive disorder. Mol. Psychiatry 11 (2006) 802-804
116. Wisniewski K.E., Wisniewski H.M., and Wen G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17 (1985) 278-282
117. Witt Engerstrom I. Age-related occurrence of signs and symptoms in the Rett syndrome. Brain Dev. 14 Suppl (1992) S11-S20
118. Wu J., and Xie X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 7 (2006) R85
119. Xu B., Roos J.L., Levy S., et al. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 40 (2008) 880-885
120. Xu X.L., Li Y., Wang F., et al. The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMR1 in Drosophila. J. Neurosci. 28 (2008) 11883-11889
121. Yu J.Y., Chung K.H., Deo M., et al. MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp. Cell Res. 314 (2008) 2618-2633
122. Zhang Y.Q., Bailey A.M., Matthies H.J., et al. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107 (2001) 591-603
123. Zhou R., Yuan P., Wang Y., et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 34 (2009) 1395-1405
124. Zimprich A., Hatala K., Riederer F., et al. Sequence analysis of the complete SLITRK1 gene in Austrian patients with Tourette's disorder. Psychiatr. Genet. 18 (2008) 308-309